https://pharmadog.xyz/news/134233 pharmadog en 2026-08-19T13:54:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/280247 pharmadog en 2026-08-19T13:33:18.000Z 11 companies hiring in New Jersey https://pharmadog.xyz/news/280248 pharmadog en 2026-08-19T13:25:41.000Z Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal https://pharmadog.xyz/news/280267 pharmadog en 2026-08-19T13:23:14.000Z STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more https://pharmadog.xyz/news/280080 pharmadog en 2026-08-19T12:29:55.000Z Trump nominates White House aide Heidi Overton as FDA commissioner https://pharmadog.xyz/news/279775 pharmadog en 2026-08-19T11:47:26.000Z Merck and Moderna report personalized mRNA vaccine delays melanoma recurrence in late-stage trial https://pharmadog.xyz/news/279667 pharmadog en 2026-08-19T11:25:12.000Z Epic’s annual meeting offers limited AI updates, highlights new customers and quirky song choices https://pharmadog.xyz/news/279647 pharmadog en 2026-08-19T11:24:41.000Z Enveda’s oral obesity pill shows strong GI safety in Phase 1, paving way for trials in patients off GLP-1 drugs https://pharmadog.xyz/news/123087 pharmadog en 2026-08-19T11:24:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/279623 pharmadog en 2026-08-19T11:05:05.000Z Biokin's EGFR-HER3 bispecific ADC succeeds in late-stage Chinese lung cancer trial https://pharmadog.xyz/news/279456 pharmadog en 2026-08-19T10:56:30.000Z Amylyx reports promising GLP-1 blocker results while Summit faces survival setbacks and Definium shows anxiety therapy benefit https://pharmadog.xyz/news/279432 pharmadog en 2026-08-19T10:45:01.000Z Merck and Moderna report Phase 3 success for personalized mRNA cancer vaccine intismeran autogene https://pharmadog.xyz/news/279476 pharmadog en 2026-08-19T10:45:00.000Z Moderna and Merck report success for personalized mRNA vaccine in late-stage melanoma trial https://pharmadog.xyz/news/280198 pharmadog en 2026-08-19T09:50:00.000Z New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem https://pharmadog.xyz/news/280199 pharmadog en 2026-08-19T09:47:00.000Z Developing a Global Clinical Trial Strategy for Emerging Biotechs https://pharmadog.xyz/news/280200 pharmadog en 2026-08-19T09:27:00.000Z How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions https://pharmadog.xyz/news/278746 pharmadog en 2026-08-19T08:30:00.000Z Immunologist Liz Marnik, raised unvaccinated, now advocates for science and empathy in vaccine discussions https://pharmadog.xyz/news/278743 pharmadog en 2026-08-19T08:30:00.000Z Accrediting body weighs dropping explicit racism language from public health curriculum standards https://pharmadog.xyz/news/278745 pharmadog en 2026-08-19T08:30:00.000Z Pediatrician warns AI chatbots may expose children to sexual content https://pharmadog.xyz/news/278744 pharmadog en 2026-08-19T08:30:00.000Z Experts split over Huidagene’s gene-editing approach after boy’s death in Duchenne trial https://pharmadog.xyz/news/278747 pharmadog en 2026-08-19T08:30:00.000Z AI fuels a parallel, unregulated medical ecosystem outside traditional care https://pharmadog.xyz/news/278280 pharmadog en 2026-08-19T07:00:00.000Z Why Biopharma Executives Should Hire an ‘Implementer’ to Turn Ideas into Action https://pharmadog.xyz/news/278207 pharmadog en 2026-08-19T06:22:29.000Z Federal appeals court revives portion of Teva's Medicare price-negotiation lawsuit amid Austedo discount plans https://pharmadog.xyz/news/277759 pharmadog en 2026-08-19T05:00:00.000Z Physician group sues HHS and USDA over alleged secret panel in dietary guideline rewrite https://pharmadog.xyz/news/277483 pharmadog en 2026-08-19T04:06:00.000Z Takeda’s FDA-approved Orzeyful expands treatment to all narcolepsy symptoms, challenging existing sleep drugs https://pharmadog.xyz/news/277484 pharmadog en 2026-08-19T04:04:00.000Z LabCentral partners with Hong Kong Science and Technology Parks to link biotech founders across US and China https://pharmadog.xyz/news/277485 pharmadog en 2026-08-19T04:03:00.000Z Novo Nordisk leads early in oral obesity market, but analysts doubt lasting advantage https://pharmadog.xyz/news/276839 pharmadog en 2026-08-19T01:24:36.000Z Trump expected to nominate Heidi Overton as new FDA commissioner https://pharmadog.xyz/news/276883 pharmadog en 2026-08-19T01:18:25.000Z Trump expected to nominate White House adviser Heidi Overton as FDA commissioner https://pharmadog.xyz/news/279382 pharmadog en 2026-08-18T23:44:00.000Z Merck and Moderna’s personalized mRNA vaccine shows longer recurrence-free survival in phase 3 melanoma trial https://pharmadog.xyz/news/276677 pharmadog en 2026-08-18T22:35:00.000Z Dreyer’s Grand Ice Cream voluntarily recalls select Outshine Fruit Bars over possible glass contamination https://pharmadog.xyz/news/275674 pharmadog en 2026-08-18T21:25:10.000Z Former NIAID adviser David Morens pleads guilty to concealing records and defrauding government https://pharmadog.xyz/news/275492 pharmadog en 2026-08-18T20:50:23.000Z Bon Secours Mercy Health receives $1.1 billion from Ensemble Health Partners stake in 2026 https://pharmadog.xyz/news/275083 pharmadog en 2026-08-18T19:54:04.000Z Academic groups sue DHS over new four-year visa limit for foreign graduate students and postdocs https://pharmadog.xyz/news/274867 pharmadog en 2026-08-18T18:42:00.000Z White House touts record drug-price drop, but critics say the claim oversimplifies the data https://pharmadog.xyz/news/274631 pharmadog en 2026-08-18T18:07:48.000Z Amylyx reports positive pivotal trial results for drug targeting post-bariatric hypoglycemia https://pharmadog.xyz/news/274567 pharmadog en 2026-08-18T17:56:30.000Z CSL Vifor warns Tavneos exit from Europe will cut revenue by about 25% https://pharmadog.xyz/news/274503 pharmadog en 2026-08-18T17:26:28.000Z Mass General and Dana-Farber CEOs receive record compensation in 2024 amid hospital cost pressures https://pharmadog.xyz/news/274135 pharmadog en 2026-08-18T16:26:00.000Z Biden-era law, not Trump, drives 2026 drop in brand-drug list prices https://pharmadog.xyz/news/273923 pharmadog en 2026-08-18T15:50:00.000Z BioMarin to buy Alesta Therapeutics for $275M, adding rare bone disease drug to pipeline https://pharmadog.xyz/news/275282 pharmadog en 2026-08-18T15:44:00.000Z Kolon TissueGene cuts 37 jobs after phase 3 osteoarthritis trial fails https://pharmadog.xyz/news/273859 pharmadog en 2026-08-18T15:25:03.000Z Epic faces mounting pressure ahead of annual customer meeting https://pharmadog.xyz/news/273815 pharmadog en 2026-08-18T15:13:00.000Z AstraZeneca’s Tagrisso plus Orpathys improves survival in MET-mutated lung cancer https://pharmadog.xyz/news/273643 pharmadog en 2026-08-18T15:02:50.000Z BioMarin signs new deal for early-stage bone disease asset https://pharmadog.xyz/news/273925 pharmadog en 2026-08-18T14:38:00.000Z Leo Pharma to acquire experimental rare-skin disease drug dersimelagon in up to $435 million deal https://pharmadog.xyz/news/273579 pharmadog en 2026-08-18T14:36:41.000Z Municipalities and States Grapple with Rising Health-Insurance Costs and Upcoming Medicaid Drug Pricing Deadline https://pharmadog.xyz/news/273535 pharmadog en 2026-08-18T14:25:50.000Z Third patient dies in Chinese trial of RiboX Therapeutics' experimental genetic therapy https://pharmadog.xyz/news/273991 pharmadog en 2026-08-18T14:10:03.000Z FDA releases discussion paper seeking input on regulation of generative AI medical devices https://pharmadog.xyz/news/275281 pharmadog en 2026-08-18T13:48:00.000Z Merck partners with Sarah Cannon to accelerate community oncology trials https://pharmadog.xyz/news/273283 pharmadog en 2026-08-18T13:33:11.000Z Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars https://pharmadog.xyz/news/273303 pharmadog en 2026-08-18T13:25:37.000Z Eyepoint’s Phase 3 trial for age‑related blindness treatment fails primary endpoint, jeopardizing approval plans https://pharmadog.xyz/news/273284 pharmadog en 2026-08-18T13:09:39.000Z LEO Pharma spends $435 million to acquire rare-disease skin drug dersimelagon https://pharmadog.xyz/news/273176 pharmadog en 2026-08-18T13:02:37.000Z Kindergarten vaccine exemptions rise as Doritos marketing sparks food-health debate https://pharmadog.xyz/news/273177 pharmadog en 2026-08-18T13:00:00.000Z GenBio AI launches AIDO Cell, a virtual model that simulates whole-cell behavior https://pharmadog.xyz/news/273087 pharmadog en 2026-08-18T12:37:45.000Z Biotech funding rebound set to boost CDMO demand by early 2027 https://pharmadog.xyz/news/272703 pharmadog en 2026-08-18T11:23:52.000Z Regeneron halts Phase 1/2 uveitis antibody trial over unfavorable risk-benefit profile https://pharmadog.xyz/news/273286 pharmadog en 2026-08-18T11:23:52.000Z Regeneron halts Phase 1/2 uveitis antibody trial after safety concerns https://pharmadog.xyz/news/272635 pharmadog en 2026-08-18T11:02:00.000Z Amylyx reports avexitide cuts severe hypoglycemia by 55% in bariatric surgery patients https://pharmadog.xyz/news/272488 pharmadog en 2026-08-18T11:01:54.000Z Amylyx reports Phase 3 success for avexitide in post-bariatric hypoglycemia https://pharmadog.xyz/news/272595 pharmadog en 2026-08-18T11:01:00.000Z Amylyx to seek FDA approval for avexitide after Phase 3 success in post-bariatric hypoglycemia https://pharmadog.xyz/news/272532 pharmadog en 2026-08-18T11:01:00.000Z Amylyx avexitide cuts serious low blood sugar events by 55% in Phase 3 trial for post bariatric hypoglycemia https://pharmadog.xyz/news/272251 pharmadog en 2026-08-18T10:00:00.000Z Enveda reports promising Phase 1 data for oral drug that mimics exercise to preserve muscle during weight loss https://pharmadog.xyz/news/273236 pharmadog en 2026-08-18T09:15:00.000Z BioMarin to acquire Alesta Therapeutics for $275 million to expand bone disease pipeline https://pharmadog.xyz/news/271800 pharmadog en 2026-08-18T08:30:00.000Z Opinion warns US surrogacy system is chaotic and may face bans after decades of legal battles https://pharmadog.xyz/news/271799 pharmadog en 2026-08-18T08:30:00.000Z Doritos market themselves as farm-to-table despite being ultra-processed, highlighting industry image push https://pharmadog.xyz/news/271801 pharmadog en 2026-08-18T08:30:00.000Z Study shows antibiotic overuse is concentrated in high-income nations, while low-income countries struggle with shortages https://pharmadog.xyz/news/271802 pharmadog en 2026-08-18T08:30:00.000Z Rising health-care costs force Pennsylvania county to raise property taxes by 22% https://pharmadog.xyz/news/273510 pharmadog en 2026-08-18T08:14:00.000Z Craif raises $33M to expand its urine-based pancreatic cancer test https://pharmadog.xyz/news/273234 pharmadog en 2026-08-18T07:53:00.000Z J&J MedTech secures FDA 510(k) clearance for Monarch Quest 3 bronchoscopy software update https://pharmadog.xyz/news/271263 pharmadog en 2026-08-18T07:00:16.000Z Leo Pharma to license Tanabe’s oral drug for rare light-sensitive skin disease, paying up to $435 million https://pharmadog.xyz/news/270687 pharmadog en 2026-08-18T04:12:00.000Z AI and data sharing essential for safer cell and gene therapies, says industry leader https://pharmadog.xyz/news/275939 pharmadog en 2026-08-18T04:00:00.000Z BD advises recall of sodium chloride ampules in convenience kits after Huons Co. issue https://pharmadog.xyz/news/270117 pharmadog en 2026-08-18T00:02:00.000Z L-Nutra recalls Prolon Apulian Almond & Cocoa Spread due to undeclared cashews, pistachios, hazelnuts https://pharmadog.xyz/news/273825 pharmadog en 2026-08-18T00:00:00.000Z Study highlights limits of premarket evaluation for identifying recalls of high-risk medical devices https://pharmadog.xyz/news/232026 pharmadog en 2026-08-18T00:00:00.000Z Drug makers and animal testing groups urge FDA to keep flexible guidance on animal studies for cancer drugs https://pharmadog.xyz/news/277297 pharmadog en 2026-08-18T00:00:00.000Z FDA updates guidance to clarify ANDA and 505(b)(2) approval pathways https://pharmadog.xyz/news/277299 pharmadog en 2026-08-18T00:00:00.000Z FDA issues draft guidance for generative AI medical devices as industry calls for German drug pricing reform https://pharmadog.xyz/news/277298 pharmadog en 2026-08-18T00:00:00.000Z Study finds measuring non-clinical influences on FDA approvals is complex https://pharmadog.xyz/news/268425 pharmadog en 2026-08-17T21:55:00.000Z Oma's Pride recalls one lot of 6 lb Woof Complete canine chicken food after Salmonella contamination https://pharmadog.xyz/news/268479 pharmadog en 2026-08-17T20:20:28.000Z Experts say AI could outperform doctors on basic tasks by 2030 https://pharmadog.xyz/news/268130 pharmadog en 2026-08-17T19:23:54.000Z Sanofi to cut 229 Massachusetts jobs a year after $9.1 billion Blueprint Medicines acquisition https://pharmadog.xyz/news/268131 pharmadog en 2026-08-17T18:45:42.000Z Eyepoint's wet AMD therapy misses primary goal in Phase 3, stock tumbles https://pharmadog.xyz/news/272438 pharmadog en 2026-08-17T18:37:00.000Z Amylyx's avexitide halves hypoglycemia episodes in phase 3 trial for post‑bariatric patients https://pharmadog.xyz/news/267526 pharmadog en 2026-08-17T17:28:00.000Z Drugmakers Back US Probe into Germany’s New Drug Pricing Policies https://pharmadog.xyz/news/267255 pharmadog en 2026-08-17T16:12:00.000Z Argenx reports positive Phase 3 results for Vyvgart Hytrulo in myositis https://pharmadog.xyz/news/266935 pharmadog en 2026-08-17T15:38:40.000Z EyePoint’s Phase 3 eye drug falls short of Eylea, stock tumbles 70% https://pharmadog.xyz/news/267132 pharmadog en 2026-08-17T15:31:00.000Z EyePoint shares tumble as Durayvu misses primary goal in wet AMD trial https://pharmadog.xyz/news/267257 pharmadog en 2026-08-17T15:13:00.000Z AstraZeneca halts Phase 3 lung cancer trial of bispecific antibody volrustomig after interim data miss survival goal https://pharmadog.xyz/news/266936 pharmadog en 2026-08-17T15:12:10.000Z Biotech raises $820M to bring China-sourced immunology drug to market via reverse merger https://pharmadog.xyz/news/266744 pharmadog en 2026-08-17T14:53:46.000Z AstraZeneca reports positive late-stage results for Tagrisso-Orpathys combo and Enhertu in lung cancer https://pharmadog.xyz/news/266745 pharmadog en 2026-08-17T14:48:39.000Z Summit and Akeso's ivonescimab wins Chinese first-line lung cancer approval, but longer follow-up shows reduced benefit https://pharmadog.xyz/news/266788 pharmadog en 2026-08-17T14:40:47.000Z IRS probes UnitedHealth tax filings and private-equity deals for doctor groups slow down https://pharmadog.xyz/news/266768 pharmadog en 2026-08-17T14:40:39.000Z EyePoint’s Phase 3 trial of duravyu fails to outperform aflibercept, shares plunge 70% https://pharmadog.xyz/news/266746 pharmadog en 2026-08-17T14:36:05.000Z Eli Lilly signs up to $370 million ion-channel collaboration with OmniAb https://pharmadog.xyz/news/267258 pharmadog en 2026-08-17T14:23:40.000Z Slate Medicines to merge with Fulcrum Therapeutics after Fulcrum drops sickle-cell drug